Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Bukwang Pharmaceutical clinical trials
The registry lists 36 studies whose lead sponsor is Bukwang Pharmaceutical or one of 2 companies grouped under it. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 16, 2026.
Keep track of what changes. Save the Bukwang Pharmaceutical studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Bukwang Pharmaceutical.
Focus areas
Conditions Bukwang Pharmaceutical leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 36 of 36.
- Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant MonotherapyNot yet recruitingNCT07781293Phase 3
- Open-Label Extension Study of ASTORIATerminatedNCT05516875Phase 2
Sponsor listed in the registry: Contera Pharma A/S · First submitted after Contera Pharma A/S became part of Bukwang Pharmaceutical
- A Study in Parkinson's Disease in Patients With Moderate to Severe DyskinesiaCompletedNCT03956979Phase 2
Sponsor listed in the registry: Contera Pharma · First submitted after Contera Pharma became part of Bukwang Pharmaceutical
- Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual ComponentsTerminatedNCT04377945Phase 2
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male SubjectsCompletedNCT06014853Phase 1
- A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With SchizophreniaCompletedNCT03465787Phase 3
- A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard TreatmentCompletedNCT02711969Phase 1
- The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19CompletedNCT04891302Phase 2
- The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19CompletedNCT04347915Phase 2
- Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBVTerminatedNCT00313274Phase 3
- Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 TrialCompletedNCT00362674
- Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201TerminatedNCT00362700Phase 2
- Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBVTerminatedNCT00313287Phase 3
- Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 TrialsTerminatedNCT00362505Phase 3
- Efficacy and Safety of JM-010 in PD With Levodopa-Induced DyskinesiaCompletedNCT02439203Phase 2
- A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long PeriodTerminatedNCT01264094Phase 4
- Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord InjuryCompletedNCT01624779Phase 1
- A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)CompletedNCT01264367Phase 4
- A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-BCompletedNCT00672867Phase 3
- Comparative Efficacy and Safety of FenoverineCompletedNCT01507922Phase 4
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCCCompletedNCT01263002Phase 4
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BTerminatedNCT01264133Phase 4
- An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BCompletedNCT01264354Phase 4
- A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV PatientsTerminatedNCT01266005Phase 4
- Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral TherapyCompletedNCT01258686Phase 3
- Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo GroupTerminatedNCT00313261Phase 2
- A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male SubjectsCompletedNCT01581242Phase 1
- Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB InfectionCompletedNCT00362635Phase 3
- Long-term Study With ClevudineCompletedNCT00558818Phase 4
- An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received ClevudineCompletedNCT01264107
- Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B PatientsCompletedNCT00558493Phase 4
- A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionCompletedNCT00641082Phase 4
- Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic NeuropathyCompletedNCT01261143Phase 3
- Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBVCompletedNCT00501124Phase 4
- A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male SubjectsCompletedNCT01258699Phase 1
- Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B VirusTerminatedNCT00305019Phase 2